Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FYSHU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,132
Award facts
- Contract value 100% obligated
- $41,131.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format, with a ceiling value of $41,131.82. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-competitive set-aside procurement utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, indicating this procurement supports federal healthcare needs for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of pharmaceutical products, vaccines, and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated consistent capability in fulfilling Defense Logistics Agency medical procurement requirements through competitive contracting, supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FYSHU?
SPE2DB25FYSHU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FYSHU worth?
The government has obligated $41,132 on SPE2DB25FYSHU.
Is contract SPE2DB25FYSHU an order under another contract?
Yes. SPE2DB25FYSHU is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYSHU competed?
The extent of competition for SPE2DB25FYSHU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award